Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347708 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration
A Phase 1 study, sponsored by DiscGenics.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT03347708 is a Phase 1 study that has completed, run by DiscGenics. The registered enrollment target is 60 participants.
The verdict
NCT03347708, a Phase 1 study, has completed, sponsored by DiscGenics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and preliminary efficacy of intradiscal injections of two doses of IDCT (Discogenic Cells + Sodium Hyaluronate vehicle) and two controls (saline, Sodium Hyaluronate vehicle) in subjects with chronic low back pain due to Degenerative Disc Disease (DDD) at one lumbar level from L3 to S1.
Interventions
- DRUG Saline Solution
- DRUG Sodium Hyaluronate
- BIOLOGICAL IDCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-02-26 |
| Est. Completion | 2022-11-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03347708
The ClinicalTrials.gov registry entry for NCT03347708 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DiscGenics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Saline Solution is the first listed.
NCT03347708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03347708 about?
NCT03347708 is a clinical study titled "Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration". The purpose of this study is to compare the safety and preliminary efficacy of intradiscal injections of two doses of IDCT (Discogenic Cells + Sodium Hyaluronate vehicle) and two controls (saline, Sodium Hyaluronate vehicle) in subjects with chronic low back pain due to Degenerative Disc Disease (DD...
What is the current status of trial NCT03347708?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2018-02-26. Estimated completion is 2022-11-10.
What interventions are being tested in trial NCT03347708?
The interventions under investigation include: Saline Solution (DRUG), Sodium Hyaluronate (DRUG), IDCT (BIOLOGICAL).
Who is sponsoring clinical trial NCT03347708?
This trial is sponsored by DiscGenics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.